271 related articles for article (PubMed ID: 17875993)
1. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
2. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
Barrow EW; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
4. New antifolate inhibitors for Mycobacterium avium.
Barrow EW; Suling WJ; Seitz LE; Reynolds RC; Barrow WW
Med Chem; 2006 Sep; 2(5):505-10. PubMed ID: 17017990
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
Bourne CR; Bunce RA; Bourne PC; Berlin KD; Barrow EW; Barrow WW
Antimicrob Agents Chemother; 2009 Jul; 53(7):3065-73. PubMed ID: 19364848
[TBL] [Abstract][Full Text] [Related]
6. Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations.
Nelson RG; Rosowsky A
Antimicrob Agents Chemother; 2001 Dec; 45(12):3293-303. PubMed ID: 11709300
[TBL] [Abstract][Full Text] [Related]
7. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
[TBL] [Abstract][Full Text] [Related]
8. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.
Lombardo MN; G-Dayanandan N; Wright DL; Anderson AC
ACS Infect Dis; 2016 Feb; 2(2):149-56. PubMed ID: 27624966
[TBL] [Abstract][Full Text] [Related]
11. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.
Lamb KM; Lombardo MN; Alverson J; Priestley ND; Wright DL; Anderson AC
Antimicrob Agents Chemother; 2014 Dec; 58(12):7484-91. PubMed ID: 25288083
[TBL] [Abstract][Full Text] [Related]
13. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
[TBL] [Abstract][Full Text] [Related]
14. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
Forsch RA; Queener SF; Rosowsky A
Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.
Bastien D; Ebert MC; Forge D; Toulouse J; Kadnikova N; Perron F; Mayence A; Huang TL; Vanden Eynde JJ; Pelletier JN
J Med Chem; 2012 Apr; 55(7):3182-92. PubMed ID: 22424148
[TBL] [Abstract][Full Text] [Related]
16. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
Beierlein JM; Karri NG; Anderson AC
J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
[TBL] [Abstract][Full Text] [Related]
18. A trimethoprim derivative impedes antibiotic resistance evolution.
Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E
Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959
[TBL] [Abstract][Full Text] [Related]
19. Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis.
Nammalwar B; Bourne CR; Wakeham N; Bourne PC; Barrow EW; Muddala NP; Bunce RA; Berlin KD; Barrow WW
Bioorg Med Chem; 2015 Jan; 23(1):203-11. PubMed ID: 25435253
[TBL] [Abstract][Full Text] [Related]
20. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.
Navarro-Martínez MD; Navarro-Perán E; Cabezas-Herrera J; Ruiz-Gómez J; García-Cánovas F; Rodríguez-López JN
Antimicrob Agents Chemother; 2005 Jul; 49(7):2914-20. PubMed ID: 15980368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
